Ng Carey
- SEC CIK
- 0001889522
No open-market purchases or sales filed in the past year.
Current role at each company
- IMMX Immix Biopharma, Inc.Directoras of May 29, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ng Carey as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2024 (view filing) | Aug 16 | 3 days | Ng CareyDirector | PPurchase | +10.0K | $1.86 | +$18.6K | +100.0%20.0K after | |
| Sep 15, 2023 (view filing) | Sep 14 | 1 day | Ng CareyDirector | PPurchase | +10.0K | $2.58 | +$25.8K | New position10.0K after | |
| Dec 20, 2021 (view filing) | Dec 20 | Same day | Ng CareyDirector | PPurchase | +25.0K | $5.00 | +$125.0K | +2.5%1.03M after |